Compare
Pediatrix Medical Group, Inc. vs Surgery Partners, Inc. vs Encompass Health Corp vs Ardent Health, Inc.
| Latest fiscal year | Pediatrix Medical Group, Inc. MD | Surgery Partners, Inc. SGRY | Encompass Health Corp EHC | Ardent Health, Inc. ARDT |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $1.91B | $3.31B | $5.94B | $6.32B |
| Revenue growth (YoY) | -4.9% | +6.2% | +10.5% | +6.0% |
| Gross margin | n/a | n/a | n/a | n/a |
| Operating margin | 10.9% | 11.8% | n/a | n/a |
| Net margin | 8.6% | -2.4% | 9.5% | 2.1% |
| Net income | $165.39M | -$77.90M | $566.20M | $135.81M |
| EPS (Diluted) | $1.94 | -$0.61 | $5.54 | $0.96 |
| Operating cash flow | $271.09M | $274.30M | $1.18B | $470.51M |
| Free cash flow | n/a | $195.60M | $439.20M | n/a |
| Cash & equivalents | $375.24M | $239.90M | $72.20M | $709.60M |
| Total assets | $2.25B | $8.12B | $7.09B | $5.29B |
| Total liabilities | $1.38B | n/a | $3.81B | $3.61B |
| Shareholders' equity | $865.85M | $3.13B | $2.44B | $1.69B |
| Return on year-end equity | 19.1% | -2.5% | 23.2% | 8.1% |
| Shares outstanding | 82.98M | 129.32M | n/a | 142.86M |
Revenue, most recent five fiscal years
| Fiscal year | Pediatrix Medical Group, Inc. | Surgery Partners, Inc. | Encompass Health Corp | Ardent Health, Inc. |
|---|---|---|---|---|
| Latest | $1.91B Ended 2025-12-31 | $3.31B Ended 2025-12-31 | $5.94B Ended 2025-12-31 | $6.32B Ended 2025-12-31 |
| 1 year earlier | $2.01B Ended 2024-12-31 | $3.11B Ended 2024-12-31 | $5.37B Ended 2024-12-31 | $5.97B Ended 2024-12-31 |
| 2 years earlier | $1.99B Ended 2023-12-31 | $2.74B Ended 2023-12-31 | $4.80B Ended 2023-12-31 | $5.41B Ended 2023-12-31 |
| 3 years earlier | $1.97B Ended 2022-12-31 | $2.54B Ended 2022-12-31 | $4.35B Ended 2022-12-31 | $5.13B Ended 2022-12-31 |
| 4 years earlier | $1.91B Ended 2021-12-31 | $2.23B Ended 2021-12-31 | $4.01B Ended 2021-12-31 | n/a |